A hemodialysis patient experienced a rash which occurred following treatment after using a xenium dialyzer.
The patient was treated with loratadine (dose, route, frequency and duration not reported).
The filter was changed, therapy end regularly and the patient was discharged.
No additional information is available.
|
A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.
The device was not received for evaluation; therefore, a device analysis could not be completed.
Should additional relevant information become available, a supplemental report will be submitted.
|